ArticleVaccine: X2022

Immunogenicity to SARS-CoV-2 Omicron variant among school-aged children with 2-dose of inactivated SARS-CoV-2 vaccines followed by BNT162b2 booster.

Napaporn Chantasrisawad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.